Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
R&D
Biotech
Gilead to lay off 72 staffers, shutter Seattle R&D office
Gilead will lay off 72 staffers in Seattle starting Jan. 17, according to a Worker Adjustment and Retraining Notification alert.
Fraiser Kansteiner
Nov 14, 2024 1:09pm
Ring calls on Singapore research agencies for gene therapy pact
Nov 6, 2024 9:59am
Kymera pivots to immunology, seeks partners for cancer assets
Nov 1, 2024 11:46am
Alnylam abandons clinical-stage Type 2 diabetes asset
Oct 31, 2024 10:27am
Amgen disappears lung disease program after phase 2 fail
Oct 30, 2024 5:59pm
Teva brings biotech ethos to drug development, exec says
Oct 15, 2024 4:33pm
